Effects of vitamin B1/B6/B12 complex on methotrexate-induced hepatorenal toxicity in a short-term acute rat model

dc.contributor.authorToprak-Semiz, Ayça
dc.contributor.authorDeniz, Esra
dc.contributor.authorTopçu, Atilla
dc.contributor.authorMataracı Karakaş, Sibel
dc.contributor.authorÖztürk,
dc.contributor.authorYavuz-Bedir, Efsane
dc.date.accessioned2026-11-18T07:59:03Z
dc.date.issued2026
dc.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.departmentRTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
dc.description.abstractThis study evaluated the effects of vitamin B1/B6/B12 complex supplementation on methotrexate (MTX)-induced hepatorenal injury in a short-term, single-dose acute rat model. Male Wistar rats were assigned to control, MTX, low-dose (MTX + VB-L), and high-dose (MTX + VB-H) vitamin B complex groups. A single MTX (20 mg/kg) was administered intraperitoneally on day 7. Vitamin B1/B6/B12 was administered intraperitoneally daily at 16/16/0.16 or 32/32/0.32 mg/kg on days 1–14. Samples were collected on day 14. Serum AST, ALT, urea, and creatinine, hepatic, and renal thiobarbituric acid reactive substances (TBARS) and total thiol (TT), and histopathological changes were evaluated. MTX significantly increased AST, urea, creatinine, hepatic and renal TBARS, and multiple histopathological scores compared with controls. Compared with MTX alone, AST and hepatic TBARS were significantly lower only in the MTX + VB-H group, whereas creatinine and renal TBARS were significantly lower in both treatment groups. Renal TBARS was significantly lower in MTX + VB-L than in MTX + VB-H. Neither the treatment group differed significantly from the MTX group in ALT, urea, TT, or any hepatic or renal histopathological parameter. Vitamin B complex co-administration was associated with improvements in selected biochemical markers and lower TBARS levels, without statistically significant histopathological improvement. The absence of a vitamin-only group limits distinction between MTX-specific attenuation and independent formulation effects. Further preclinical studies are required before clinical implications can be established.
dc.identifier.citationToprak-Semiz, A., Deniz, E., Topçu, A., Mataracı Karakaş, S., Öztürk, Ç., & Yavuz-Bedir, E. (2026). Effects of vitamin B1/B6/B12 complex on methotrexate-induced hepatorenal toxicity in a short-term acute rat model. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05993-4
dc.identifier.doi10.1007/s00210-026-05993-4
dc.identifier.issn0028-1298
dc.identifier.scopus2-s2.0-105053275589
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1007/s00210-026-05993-4
dc.identifier.urihttps://hdl.handle.net/11436/13821
dc.indekslendigikaynakScopus
dc.institutionauthorToprak Semiz, Ayça
dc.institutionauthorDeniz, Esra
dc.institutionauthorTopçu, Atilla
dc.institutionauthorMataracı Karakaş, Sibel
dc.institutionauthorid0000-0001-7147-5087
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofNaunyn-Schmiedeberg's Archives of Pharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAcute hepatorenal toxicity
dc.subjectLipid peroxidation
dc.subjectMethotrexate
dc.subjectOxidative stress
dc.subjectVitamin B complex
dc.titleEffects of vitamin B1/B6/B12 complex on methotrexate-induced hepatorenal toxicity in a short-term acute rat model
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
toprak-2026.pdf
Boyut:
2.66 MB
Biçim:
Adobe Portable Document Format

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: